CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability

Cell Metab. 2021 May 4;33(5):1001-1012.e5. doi: 10.1016/j.cmet.2021.02.015. Epub 2021 Mar 9.

Abstract

Understanding the mechanisms underlying how T cells become dysfunctional in a tumor microenvironment (TME) will greatly benefit cancer immunotherapy. We found that increased CD36 expression in tumor-infiltrating CD8+ T cells, which was induced by TME cholesterol, was associated with tumor progression and poor survival in human and murine cancers. Genetic ablation of Cd36 in effector CD8+ T cells exhibited increased cytotoxic cytokine production and enhanced tumor eradication. CD36 mediated uptake of fatty acids by tumor-infiltrating CD8+ T cells in TME, induced lipid peroxidation and ferroptosis, and led to reduced cytotoxic cytokine production and impaired antitumor ability. Blocking CD36 or inhibiting ferroptosis in CD8+ T cells effectively restored their antitumor activity and, more importantly, possessed greater antitumor efficacy in combination with anti-PD-1 antibodies. This study reveals a new mechanism of CD36 regulating the function of CD8+ effector T cells and therapeutic potential of targeting CD36 or inhibiting ferroptosis to restore T cell function.

Keywords: CD36; CD8(+) T cells; ferroptosis; lipid peroxidation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antibodies, Monoclonal, Humanized / pharmacology
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • CD36 Antigens / antagonists & inhibitors
  • CD36 Antigens / genetics
  • CD36 Antigens / metabolism*
  • CD8-Positive T-Lymphocytes / cytology
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism
  • Cell Line, Tumor
  • Cytokines / metabolism
  • Fatty Acids / metabolism
  • Ferroptosis* / drug effects
  • Humans
  • Immunotherapy
  • Lipid Peroxidation
  • Melanoma, Experimental / drug therapy
  • Melanoma, Experimental / therapy
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / mortality
  • Multiple Myeloma / therapy
  • Reactive Oxygen Species / metabolism
  • Survival Rate
  • Tumor Microenvironment

Substances

  • Antibodies, Monoclonal, Humanized
  • CD36 Antigens
  • Cytokines
  • Fatty Acids
  • Reactive Oxygen Species
  • spartalizumab